United States · FDA National Drug Code directory
Methocarbamol
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 43063-905_32d38d53-d181-0b14-e063-6394a90ae577
- Product NDC
- 43063-905
- Form
- TABLET, COATED
- Composition / generic term
- Methocarbamol Tablets
- Labeler
- PD-Rx Pharmaceuticals, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20180702
- Source listing expiry
- 20261231
Source-listed ingredients
- METHOCARBAMOL — 750 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 14 TABLET, COATED in 1 BOTTLE, PLASTIC (43063-905-14) · 43063-905-14
- 20 TABLET, COATED in 1 BOTTLE, PLASTIC (43063-905-20) · 43063-905-20
- 30 TABLET, COATED in 1 BOTTLE, PLASTIC (43063-905-30) · 43063-905-30
- 40 TABLET, COATED in 1 BOTTLE, PLASTIC (43063-905-40) · 43063-905-40
- 60 TABLET, COATED in 1 BOTTLE, PLASTIC (43063-905-60) · 43063-905-60
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →